Conflicting results exist on the analysis of relationship between clinicopathological parameters and Gal-3 expression (Jiang et al., 2014; Matsuda et al., 2008) and the limited reports of Gal-9 in HCC in previous literatures. This evidence concerns the gene LGALS9 and hepatocellular carcinoma.